Last quarter (Q ), Organicell Regenerative Medicine's total revenue was $1.42M, a decrease of -1.50% from the same quarter last year. In Q, Organicell Regenerative Medicine's net income was $-1.09M. See Organicell Regenerative Medicine’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Oct 23	Oct 22	Oct 21	Oct 20	Oct 19
Total Revenue	$ 4.56M	$ 4.56M	$ 6.49M	$ 5.60M	$ 3.06M	$ 1.70M
Cost of Revenue	$ 345.30K	$ 507.63K	$ 753.53K	$ 547.88K	$ 398.61K	$ 300.84K
Gross Profit	$ 4.21M	$ 4.05M	$ 5.74M	$ 5.05M	$ 2.66M	$ 1.40M
Operating Expense	$ 10.95M	$ 11.33M	$ 14.61M	$ 17.79M	$ 15.10M	$ 3.18M
Operating Income	$ -6.60M	$ -6.77M	$ -8.87M	$ -12.74M	$ -12.44M	$ -1.78M
Net Non Operating Interest Income Expense	$ -431.42K	$ -431.42K	$ -398.26K	$ -37.93K	$ -177.74K	$ -46.60K
Other Income Expense	$ -281.23K	$ -330.61K	$ -375.36K	$ -25.48K	$ -32.72K	$ 84.79K
Pretax Income	$ -6.71M	$ -6.87M	$ -8.90M	$ -12.76M	$ -12.58M	$ -1.74M
Tax Provision	$ -752.32K	$ -734.65K	-	$ -90.00K	$ -2.78K	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -6.99M	$ -6.99M	$ -8.90M	$ -12.76M	$ -12.58M	$ -1.74M
Basic EPS	$ -0.05	$ -0.99	-	-	-	-
Diluted EPS	$ -0.05	$ -0.99	-	$ -0.01	$ -0.02	-
Basic Average Shares	$ 1.44B	$ 7.03M	-	$ 1.06B	$ 670.82M	-
Diluted Average Shares	$ 1.44B	$ 7.03M	-	$ 1.06B	$ 670.82M	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 11.30M	$ 11.83M	$ 15.36M	$ 18.34M	$ 15.49M	$ 3.48M
Net Income From Continuing And Discontinued Operation	$ -6.99M	$ -6.99M	$ -8.90M	$ -12.76M	$ -12.58M	$ -1.74M
Normalized Income	$ -3.23M	$ -7.94M	-	-	-	$ -1.74M
Interest Expense	-	-	-	-	-	$ 46.60K
EBIT	$ -6.27M	$ -6.44M	$ -8.50M	$ -12.72M	$ -12.41M	$ -1.69M
EBITDA	$ -5.44M	$ -5.60M	$ -7.84M	$ -12.67M	$ -12.37M	$ -1.68M

Currency in USD

Organicell Regenerative Medicine Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing